{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:14:41Z","timestamp":1792206881900,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cld.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:43:54Z","timestamp":1615423434000},"page":"311-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers"],"prefix":"10.1016","volume":"25","author":[{"given":"Mathias","family":"Jachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib1","first-page":"281","article-title":"Pathophysiology of portal hypertension","volume":"18","author":"Iwakiri","year":"2014","journal-title":"Portal Hypertens"},{"issue":"10","key":"10.1016\/j.cld.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"issue":"160","key":"10.1016\/j.cld.2021.01.004_bib4","article-title":"Measurement of the hepatic venous pressure gradient and transjugular liver biopsy","author":"Reiberger","year":"2020","journal-title":"J\u00a0Vis Exp"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A\u00a0MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.cld.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","volume":"324","author":"Poynard","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.20284","article-title":"Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis","volume":"40","author":"Schepke","year":"2004","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.cld.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198112033052302","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study","volume":"305","author":"Lebrec","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-149-2-200807150-00007","article-title":"Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis","volume":"149","author":"Gonzalez","year":"2008","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.cld.2021.01.004_bib11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.23045","article-title":"Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed","volume":"50","author":"Tripathi","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.14576","article-title":"Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study","volume":"47","author":"Schwarzer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2021.01.004_bib14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/apt.14485","article-title":"Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding","volume":"47","author":"Pfisterer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2016.01.012","article-title":"Nonselective \u03b2-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis","volume":"14","author":"Chirapongsathorn","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.53.1.143","article-title":"Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence","volume":"53","author":"Thalheimer","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.cld.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11901-019-00469-x","article-title":"Hepatic venous pressure gradient response in non-selective beta-blocker treatment\u2014is it worth measuring?","volume":"18","author":"Mandorfer","year":"2019","journal-title":"Curr Hepatol Rep"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2004.01.017","article-title":"Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis","volume":"40","author":"Villanueva","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2009.10.014","article-title":"Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria","volume":"52","author":"Merkel","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to \u03b2-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"10.1016\/j.cld.2021.01.004_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","article-title":"Noninvasive screening for liver fibrosis and portal hypertension by transient elastography\u2014a large single center experience","volume":"124","author":"Reiberger","year":"2012","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the \u201cAnticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jhep.2013.10.027","article-title":"Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study","volume":"60","author":"Augustin","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1148\/radiol.14140008","article-title":"Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis","volume":"273","author":"Choi","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","article-title":"Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices","volume":"70","author":"Kim","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jhep.2016.07.021","article-title":"Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging","volume":"65","author":"Palaniyappan","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2016.01.022","article-title":"Assessment of response to beta-blockers by expression of \u03b2Arr2 and RhoA\/ROCK2 in antrum mucosa in cirrhotic patients","volume":"64","author":"Trebicka","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/liv.14042","article-title":"Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis","volume":"39","author":"Reverter","year":"2019","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib43","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.29056","article-title":"A\u00a0randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis","volume":"65","author":"Villanueva","year":"2017","journal-title":"Hepatology"},{"issue":"10181","key":"10.1016\/j.cld.2021.01.004_bib44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","article-title":"A\u00a0placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 1","volume":"127","author":"Merkel","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.004_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","article-title":"Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial","volume":"7","author":"Sarin","year":"2013","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.cld.2021.01.004_bib47","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3748\/wjg.v21.i10.3100","article-title":"Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis","volume":"21","author":"Qi","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2021.01.004_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gutjnl-2016-312814","article-title":"Prevention of progression from small to large varices: are we there yet? An updated meta-analysis","volume":"66","author":"Mandorfer","year":"2017","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cld.2021.01.004_bib49","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/gutjnl-2016-311735","article-title":"Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial","volume":"66","author":"Bhardwaj","year":"2017","journal-title":"Gut"},{"issue":"04","key":"10.1016\/j.cld.2021.01.004_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib51","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.28575","article-title":"Propranolol use beyond 6\u00a0months increases mortality in patients with Child-Pugh C cirrhosis and ascites: correspondence","volume":"64","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2021.01.004_bib52","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/gutjnl-2016-311527","article-title":"Red signs and not severity of cirrhosis should determine non-selective \u03b2-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6\u00a0months of propranolol use","volume":"65","author":"Kalambokis","year":"2016","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2021.01.004_bib53","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib54","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/hep.30220","article-title":"Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis","volume":"69","author":"Sharma","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib55","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.30856","article-title":"Letter to the editor: beta-blockers are preferable to banding ligation for primary prophylaxis of variceal bleeding?","volume":"70","author":"Lo","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2021.01.004_bib56","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/gutjnl-2012-304182","article-title":"Carvedilol: the \u03b2-blocker of choice for portal hypertension?","volume":"62","author":"Bosch","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2013.11.019","article-title":"Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial","volume":"60","author":"Shah","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2021.01.004_bib59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding: prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib60","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2021.01.004_bib61","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2036.2012.05074.x","article-title":"Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices","volume":"35","author":"Thiele","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/liv.12452","article-title":"Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review","volume":"34","author":"Puente","year":"2014","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib63","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/gast.2002.35955","article-title":"A\u00a0randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis","volume":"123","author":"Patch","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.004_bib64","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"T\u00e9llez","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib65","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jhep.2016.01.031","article-title":"Keep the sick from harm in spontaneous bacterial peritonitis: dose of beta blockers matters","volume":"64","author":"Madsen","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib66","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/hep.28502","article-title":"Beta-blockers in 2016: still the safest and most useful drugs for portal hypertension? D\u2019Amico et\u00a0al","volume":"63","author":"D\u2019Amico","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.004_bib67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2015.12.012","article-title":"Beta blockers in cirrhosis: the window re-opens","volume":"64","author":"Garcia-Tsao","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.004_bib68","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.28352","article-title":"Nonselective \u03b2-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three randomized controlled trials with 1198 patients: liver Failure\/Cirrhosis\/Portal Hypertension","volume":"63","author":"Bossen","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2021.01.004_bib69","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective \u03b2-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2012.03.018","article-title":"Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites","volume":"57","author":"Serst\u00e9","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib71","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"issue":"01","key":"10.1016\/j.cld.2021.01.004_bib72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2021.01.004_bib73","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"issue":"8982","key":"10.1016\/j.cld.2021.01.004_bib74","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2021.01.004_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2021.01.004_bib76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11901-018-0420-z","article-title":"Small esophageal varices in patients with cirrhosis-should we treat them?","volume":"17","author":"Reiberger","year":"2018","journal-title":"Curr Hepatol Rep"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2021.01.004_bib77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","article-title":"Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)","volume":"129","author":"Reiberger","year":"2017","journal-title":"Wien Klin Wochenschr"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:57:58Z","timestamp":1761069478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1089326121000040"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}